Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2021-03-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-021-00443-1 |
| id |
doaj-5034355e2436472d9133161b489aabbc |
|---|---|
| record_format |
Article |
| spelling |
doaj-5034355e2436472d9133161b489aabbc2021-03-11T11:30:24ZengNature Publishing GroupBlood Cancer Journal2044-53852021-03-011131610.1038/s41408-021-00443-1Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemiaPaul J. Hampel0Sameer A. Parikh1Timothy G. Call2Mithun V. Shah3N. Nora Bennani4Aref Al-Kali5Kari G. Rabe6Yucai Wang7Eli Muchtar8Jose F. Leis9Saad S. Kenderian10Amber B. Koehler11Susan M. Schwager12Susan L. Slager13Neil E. Kay14Curtis A. Hanson15Daniel L. Van Dyke16Min Shi17Wei Ding18Division of Hematology, Department of Medicine, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDivision of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDepartment of Hematology and Oncology, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDivision of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo ClinicDepartment of Laboratory Medicine and Pathology, Mayo ClinicDepartment of Laboratory Medicine and Pathology, Mayo ClinicDepartment of Laboratory Medicine and Pathology, Mayo ClinicDivision of Hematology, Department of Medicine, Mayo Clinichttps://doi.org/10.1038/s41408-021-00443-1 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Paul J. Hampel Sameer A. Parikh Timothy G. Call Mithun V. Shah N. Nora Bennani Aref Al-Kali Kari G. Rabe Yucai Wang Eli Muchtar Jose F. Leis Saad S. Kenderian Amber B. Koehler Susan M. Schwager Susan L. Slager Neil E. Kay Curtis A. Hanson Daniel L. Van Dyke Min Shi Wei Ding |
| spellingShingle |
Paul J. Hampel Sameer A. Parikh Timothy G. Call Mithun V. Shah N. Nora Bennani Aref Al-Kali Kari G. Rabe Yucai Wang Eli Muchtar Jose F. Leis Saad S. Kenderian Amber B. Koehler Susan M. Schwager Susan L. Slager Neil E. Kay Curtis A. Hanson Daniel L. Van Dyke Min Shi Wei Ding Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia Blood Cancer Journal |
| author_facet |
Paul J. Hampel Sameer A. Parikh Timothy G. Call Mithun V. Shah N. Nora Bennani Aref Al-Kali Kari G. Rabe Yucai Wang Eli Muchtar Jose F. Leis Saad S. Kenderian Amber B. Koehler Susan M. Schwager Susan L. Slager Neil E. Kay Curtis A. Hanson Daniel L. Van Dyke Min Shi Wei Ding |
| author_sort |
Paul J. Hampel |
| title |
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_short |
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_full |
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_fullStr |
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_full_unstemmed |
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia |
| title_sort |
venetoclax treatment of patients with relapsed t-cell prolymphocytic leukemia |
| publisher |
Nature Publishing Group |
| series |
Blood Cancer Journal |
| issn |
2044-5385 |
| publishDate |
2021-03-01 |
| url |
https://doi.org/10.1038/s41408-021-00443-1 |
| work_keys_str_mv |
AT pauljhampel venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT sameeraparikh venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT timothygcall venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT mithunvshah venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT nnorabennani venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT arefalkali venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT karigrabe venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT yucaiwang venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT elimuchtar venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT josefleis venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT saadskenderian venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT amberbkoehler venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT susanmschwager venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT susanlslager venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT neilekay venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT curtisahanson venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT daniellvandyke venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT minshi venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia AT weiding venetoclaxtreatmentofpatientswithrelapsedtcellprolymphocyticleukemia |
| _version_ |
1724225487198224384 |